270
Participants
Start Date
April 1, 2026
Primary Completion Date
July 1, 2028
Study Completion Date
July 1, 2028
no NSAID
no NSAID but a placebo with identical galenic formulations to maintain blindness at all times during participation in the study
protocol for administering NSAIDs already used in routine care
"* 100 mg ketoprofen LP orally administered 30 minutes before surgery,~* 50 mg ketoprofen intravenously at the end of surgery~* then 100 mg ketoprofen LP PO twice a day for 7 days following surgery"
University Hospital, Strasbourg, France
OTHER